Avricore Health, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA0545211090
CAD
0.05
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Avricore Health, Inc. stock-summary
stock-summary
Avricore Health, Inc.
Pharmaceuticals & Biotechnology
Avricore Health Inc. is a Canada-based healthcare technology company. The Company distributes a technology platform, HealthTab, which consists of point of care screening devices and related supplies and training materials, along with a real-time data reporting networking. HealthTab is designed to offer a screening system within pharmacies to enable patients to be active about health by measuring and monitoring safety tests and biomarkers of chronic disease. Rapid Access Safety Test Reporting (RASTR), is a cloud-based network technology that enables the real-time response system to automatically report data to the consumer, healthcare team, and research entities through a Web-enabled blood chemistry analyzer, Piccolo Xpress.
Company Coordinates stock-summary
Company Details
1177 West Hastings Street, Suite 2300 , VANCOUVER BC : V6E 2K3
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. David Hall
Independent Chairman of the Board
Mr. Sukhwinder Rai
President, Director
Mr. Hector Bremner
Chief Executive Officer, Director
Mr. David Farnfield
Director
Mr. Alan Arnstein
Independent Director
Dr. Robert Sindelar
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
0 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 6 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.53

stock-summary
Return on Equity

-40.45%

stock-summary
Price to Book

3.75